Cargando…

Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report

Pancreatic hepatoid carcinoma (HC) is a heterogeneous tumor with high degree of malignancy and poor prognosis, which display cytological and/or structural features of focal hepatocellular carcinoma (HCC). For the low incidence and atypical clinical symptoms, it is possible to be diagnosed as pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jintong, Zhao, Qinying, Liu, Qiang, Li, Fei, He, Long, Liu, Mengyi, Yan, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405218/
https://www.ncbi.nlm.nih.gov/pubmed/34471360
http://dx.doi.org/10.2147/OTT.S323811
_version_ 1783746285316079616
author He, Jintong
Zhao, Qinying
Liu, Qiang
Li, Fei
He, Long
Liu, Mengyi
Yan, Xiong
author_facet He, Jintong
Zhao, Qinying
Liu, Qiang
Li, Fei
He, Long
Liu, Mengyi
Yan, Xiong
author_sort He, Jintong
collection PubMed
description Pancreatic hepatoid carcinoma (HC) is a heterogeneous tumor with high degree of malignancy and poor prognosis, which display cytological and/or structural features of focal hepatocellular carcinoma (HCC). For the low incidence and atypical clinical symptoms, it is possible to be diagnosed as pancreatic cancer before operation, and mainly depending on the pathological examination. To the best of our knowledge, surgery combined with radiotherapy and chemotherapy is the common treatment of pancreatic HC. However, the curative effect and prognosis is poor. We report a case of 44-year-old woman with pancreatic HC treated with PD-1 receptor inhibitor and transarterial chemoembolization, whose clinical symptoms and laboratory indexes are significantly improved after treatment.
format Online
Article
Text
id pubmed-8405218
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84052182021-08-31 Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report He, Jintong Zhao, Qinying Liu, Qiang Li, Fei He, Long Liu, Mengyi Yan, Xiong Onco Targets Ther Case Report Pancreatic hepatoid carcinoma (HC) is a heterogeneous tumor with high degree of malignancy and poor prognosis, which display cytological and/or structural features of focal hepatocellular carcinoma (HCC). For the low incidence and atypical clinical symptoms, it is possible to be diagnosed as pancreatic cancer before operation, and mainly depending on the pathological examination. To the best of our knowledge, surgery combined with radiotherapy and chemotherapy is the common treatment of pancreatic HC. However, the curative effect and prognosis is poor. We report a case of 44-year-old woman with pancreatic HC treated with PD-1 receptor inhibitor and transarterial chemoembolization, whose clinical symptoms and laboratory indexes are significantly improved after treatment. Dove 2021-08-26 /pmc/articles/PMC8405218/ /pubmed/34471360 http://dx.doi.org/10.2147/OTT.S323811 Text en © 2021 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
He, Jintong
Zhao, Qinying
Liu, Qiang
Li, Fei
He, Long
Liu, Mengyi
Yan, Xiong
Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title_full Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title_fullStr Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title_full_unstemmed Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title_short Surgical Resection of Pancreatic Hepatoid Carcinoma Followed by Combined Transarterial Chemoembolization and Immunotherapy: A Case Report
title_sort surgical resection of pancreatic hepatoid carcinoma followed by combined transarterial chemoembolization and immunotherapy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405218/
https://www.ncbi.nlm.nih.gov/pubmed/34471360
http://dx.doi.org/10.2147/OTT.S323811
work_keys_str_mv AT hejintong surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT zhaoqinying surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT liuqiang surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT lifei surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT helong surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT liumengyi surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport
AT yanxiong surgicalresectionofpancreatichepatoidcarcinomafollowedbycombinedtransarterialchemoembolizationandimmunotherapyacasereport